The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Testosterone Administration Suppresses Adiponectin Levels in Men
Open accessAbstract
ABSTRACT: Testosterone (T) administration to men increases lean body mass and decreases fat mass. Adiponectin is produced by adipocytes and is thought to influence insulin sensitivity. In this study, we sought to determine whether experimental alterations in serum T change adiponectin levels in normal men. We measured adiponectin levels in 28 healthy men ages 18–35 years before and during treatment with a potent gonadotropin‐releasing‐hormone (GnRH) antagonist, acyline. Decreased T levels led to increased serum adiponectin within 7 days; maximal adiponectin levels were reached on day 21 (baseline 8.6 ± 0.9 compared with 12.2 ± 1.0 μg/mL on day 21, P < .05) and persisted through day 30, despite no significant changes in body mass index (BMI) and an increase in leptin. The addition of T to acyline, maintaining serum T levels within the normal range, prevented the increase in adiponectin following acyline alone. In a second study, 25 men aged 55–85 years were treated with 3 weeks of high‐dose T (testosterone enanthate [TE], 600 mg/wk intramuscularly). With high serum T levels, adiponectin levels decreased significantly by day 21 of treatment (baseline 14.3 ± 1.9 compared with 10.8 ± 1.5 μg/mL, P < .05 vs baseline and placebo), BMI slightly increased, and leptin levels were decreased. We conclude that adiponectin levels increase within days of experimental T deficiency in normal men, and the increase in adiponectin is prevented by T replacement. Furthermore, supraphysiologic T administration results in decreased adiponectin levels. Our data support the hypothesis that T, its metabolites, or both directly suppress adipocyte production of adiponectin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Yang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2734 · Cited by 837
Effects of Testosterone Replacement in Hypogonadal Men
Snyder, P. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2670 · Cited by 464
Haffner, S. M., Shaten, J., Stem, M. P., Smith, G. D., Kuller, L., & MRFIT Research Group (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008832 · Cited by 320
Research works printed but not linked: 40
- 10.1046/j.1532-5415.2002.50462.x · DOI
- 10.1046/j.1365-2265.2002.01551.x · DOI · Paper page
- 10.1016/S1043-2760(01)00524-0 · DOI · Paper page
- 10.1056/NEJM199607043350101 · DOI · Paper page
- 10.1210/jc.82.2.407 · DOI · Paper page
- 10.1007/s00125-003-1074-z · DOI · Paper page
- 10.1152/ajpcell.1998.274.6.C1645 · DOI · Paper page
- 10.1042/CS20020209 · doi:10.1042/cs20020209 · Paper page
- 10.1210/jc.2003-030219 · DOI
- 10.1001/jama.289.14.1799 · DOI · Paper page
- 10.1210/jcem-68-5-971 · DOI
- 10.1034/j.1601-5215.2002.51018.x · DOI · Paper page
- 10.1074/jbc.274.23.16147 · DOI
- 10.1152/ajpendo.00524.2002 · DOI
- Herbst KL, 2002, Acyline: the first study in humans of a potent, new gonadotropin‐releasing hormone antagonist, J Clin Endocrinol Metab, 87, 3215, 10.1210/jcem.87.7.8675 · DOI
- 10.1210/jc.2002-020918 · DOI
- Herbst KL, A single dose of the potent gonadotropin releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men, JCEM
- 10.1161/01.ATV.20.6.1595 · DOI · Paper page
- 10.2337/diabetes.50.5.1126 · DOI · Paper page
- 10.2337/diabetes.52.7.1655 · DOI · Paper page
- 10.1074/jbc.C200251200 · DOI · Paper page
- 10.1111/j.1365-2265.2004.02007.x · DOI · Paper page
- 10.1530/eje.0.1480055 · DOI
- Lovejoy JC, 1995, Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men, Int J Obes Relat Metab Disord, 19, 614
- 10.2337/diabetes.50.9.2094 · DOI · Paper page
- Marin P., 1992, The effects of testosterone treatment on body composition and metabolism in middle‐aged obese men, Int J Obes Relat Metab Disord, 16, 991
- Marin P., 1992, Androgen treatment of middle‐aged, obese men: effects on metabolism, muscle and adipose tissues, Eur J Med, 1, 329
- 10.1042/0264-6021:3610629 · doi:10.1042/0264-6021:3610629
- 10.1373/49.4.650 · DOI
- 10.1210/en.2003-0580 · DOI · Paper page
- 10.1152/ajpendo.00363.2002 · DOI
- 10.1016/S0960-9822(98)70133-2 · DOI · Paper page
- 10.1210/jcem.87.1.8172 · doi:10.1210/jcem.87.1.8172 · Paper page
- 10.1210/en.2003-0741 · DOI · Paper page
- 10.1210/jcem.86.9.7851 · DOI · Paper page
- 10.1210/jc.2003-031492 · DOI · Paper page
- 10.1038/90984 · DOI · Paper page
- 10.1210/jcem.86.8.7741 · doi:10.1210/jcem.86.8.7741 · Paper page
- 10.1073/pnas.93.11.5517 · DOI · Paper page
- 10.2337/diabetes.51.10.2968 · DOI · Paper page
Cited by
The Role of Adiponectin in Cancer: A Review of Current Evidence
Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 640
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1933 · Cited by 566
Self-citationKelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Reactive oxygen species and male reproductive hormones
Darbandi, M., Darbandi, S., Agarwal, A., Sengupta, P., Durairajanayagam, D., Henkel, R., & Sadeghi, M. R. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0406-2 · Cited by 379
Metadata
- Authors
- Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2005-01-02
- Volume
- 26
- Issue
- 1
- Pages
- 85-92
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W1569805885
- Cited by
- 162
- References
- 6
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Testosterone Administration Suppresses Adiponectin Levels in Men. https://app.cochat.ai/papers/10.1002/j.1939-4640.2005.tb02876.x
- The paper
- Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J. (2005). Testosterone Administration Suppresses Adiponectin Levels in Men. Journal of Andrology. https://doi.org/10.1002/j.1939-4640.2005.tb02876.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.